BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 10864051)

  • 1. Cognitive sequelae in children treated for acute lymphoblastic leukemia with dexamethasone or prednisone.
    Waber DP; Carpentieri SC; Klar N; Silverman LB; Schwenn M; Hurwitz CA; Mullenix PJ; Tarbell NJ; Sallan SE
    J Pediatr Hematol Oncol; 2000; 22(3):206-13. PubMed ID: 10864051
    [TBL] [Abstract][Full Text] [Related]  

  • 2. No major cognitive impairment in young children with acute lymphoblastic leukemia using chemotherapy only: a prospective longitudinal study.
    Kingma A; Van Dommelen RI; Mooyaart EL; Wilmink JT; Deelman BG; Kamps WA
    J Pediatr Hematol Oncol; 2002 Feb; 24(2):106-14. PubMed ID: 11990695
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intensive BFM chemotherapy for childhood ALL: interim analysis of the AIEOP-ALL 91 study. Associazione Italiana Ematologia Oncologia Pediatrica.
    Conter V; Aricò M; Valsecchi MG; Rizzari C; Testi A; Miniero R; Di Tullio MT; Lo Nigro L; Pession A; Rondelli R; Messina C; Santoro N; Mori PG; De Rossi G; Tamaro P; Silvestri D; Biondi A; Basso G; Masera G
    Haematologica; 1998 Sep; 83(9):791-9. PubMed ID: 9825576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurodevelopmental outcome of infants with acute lymphoblastic leukemia: a Children's Cancer Group report.
    Kaleita TA; Reaman GH; MacLean WE; Sather HN; Whitt JK
    Cancer; 1999 Apr; 85(8):1859-65. PubMed ID: 10223582
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extended intrathecal methotrexate may replace cranial irradiation for prevention of CNS relapse in children with intermediate-risk acute lymphoblastic leukemia treated with Berlin-Frankfurt-Münster-based intensive chemotherapy. The Associazione Italiana di Ematologia ed Oncologia Pediatrica.
    Conter V; Aricò M; Valsecchi MG; Rizzari C; Testi AM; Messina C; Mori PG; Miniero R; Colella R; Basso G
    J Clin Oncol; 1995 Oct; 13(10):2497-502. PubMed ID: 7595699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pediatric acute lymphoblastic leukemia: redefining outcomes.
    Kadan-Lottick N; Neglia JP
    J Pediatr Hematol Oncol; 2002 Feb; 24(2):88. PubMed ID: 11990711
    [No Abstract]   [Full Text] [Related]  

  • 7. Cognitive outcomes following contemporary treatment without cranial irradiation for childhood acute lymphoblastic leukemia.
    Conklin HM; Krull KR; Reddick WE; Pei D; Cheng C; Pui CH
    J Natl Cancer Inst; 2012 Sep; 104(18):1386-95. PubMed ID: 22927505
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cognitive sequelae of treatment in childhood acute lymphoblastic leukemia: cranial radiation requires an accomplice.
    Waber DP; Tarbell NJ; Fairclough D; Atmore K; Castro R; Isquith P; Lussier F; Romero I; Carpenter PJ; Schiller M
    J Clin Oncol; 1995 Oct; 13(10):2490-6. PubMed ID: 7595698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dental abnormalities in children after chemotherapy treatment for acute lymphoid leukemia.
    Minicucci EM; Lopes LF; Crocci AJ
    Leuk Res; 2003 Jan; 27(1):45-50. PubMed ID: 12479851
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Repetitive low dose oral methotrexate and intravenous mercaptopurine treatment for patients with lower risk B-lineage acute lymphoblastic leukemia. A Pediatric Oncology Group pilot study.
    Mahoney DH; Camitta BM; Leventhal BG; Shuster JJ; Civin CJ; Ganick DJ; Lauer SJ; Steuber CP; Kamen BA
    Cancer; 1995 May; 75(10):2623-31. PubMed ID: 7736409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Leukoencephalopathy and long-term neurobehavioural, neurocognitive, and brain imaging outcomes in survivors of childhood acute lymphoblastic leukaemia treated with chemotherapy: a longitudinal analysis.
    Cheung YT; Sabin ND; Reddick WE; Bhojwani D; Liu W; Brinkman TM; Glass JO; Hwang SN; Srivastava D; Pui CH; Robison LL; Hudson MM; Krull KR
    Lancet Haematol; 2016 Oct; 3(10):e456-e466. PubMed ID: 27658980
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Favorable outcome for children and adolescents with T-cell lymphoblastic lymphoma with an intensive ALL-type therapy without local radiotherapy.
    Grenzebach J; Schrappe M; Ludwig WD; Parwaresch R; Zimmermann M; Gadner H; Riehm H; Reiter A;
    Ann Hematol; 2001; 80 Suppl 3():B73-6. PubMed ID: 11757713
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Substituting dexamethasone for prednisone complicates remission induction in children with acute lymphoblastic leukemia.
    Hurwitz CA; Silverman LB; Schorin MA; Clavell LA; Dalton VK; Glick KM; Gelber RD; Sallan SE
    Cancer; 2000 Apr; 88(8):1964-9. PubMed ID: 10760775
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pulses of vincristine and dexamethasone in addition to intensive chemotherapy for children with intermediate-risk acute lymphoblastic leukaemia: a multicentre randomised trial.
    Conter V; Valsecchi MG; Silvestri D; Campbell M; Dibar E; Magyarosy E; Gadner H; Stary J; Benoit Y; Zimmermann M; Reiter A; Riehm H; Masera G; Schrappe M
    Lancet; 2007 Jan; 369(9556):123-31. PubMed ID: 17223475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of children with acute lymphoblastic leukemia by the Dana-Farber Cancer Institute protocols. An update of the Ontario experience.
    Barr RD; DeVeber LL; Pai KM; Andrew M; Halton J; Cairney AE; Whitton AC
    Am J Pediatr Hematol Oncol; 1992 May; 14(2):136-9. PubMed ID: 1530118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuropsychological outcomes from a randomized trial of triple intrathecal chemotherapy compared with 18 Gy cranial radiation as CNS treatment in acute lymphoblastic leukemia: findings from Dana-Farber Cancer Institute ALL Consortium Protocol 95-01.
    Waber DP; Turek J; Catania L; Stevenson K; Robaey P; Romero I; Adams H; Alyman C; Jandet-Brunet C; Neuberg DS; Sallan SE; Silverman LB
    J Clin Oncol; 2007 Nov; 25(31):4914-21. PubMed ID: 17971588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Magnetic resonance imaging detection of avascular necrosis of the bone in children receiving intensive prednisone therapy for acute lymphoblastic leukemia or non-Hodgkin lymphoma.
    Ribeiro RC; Fletcher BD; Kennedy W; Harrison PL; Neel MD; Kaste SC; Sandlund JT; Rubnitz JE; Razzouk BI; Relling MV; Pui CH
    Leukemia; 2001 Jun; 15(6):891-7. PubMed ID: 11417473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Results of the PETHEMA ALL-96 trial in elderly patients with Philadelphia chromosome-negative acute lymphoblastic leukemia.
    Sancho JM; Ribera JM; Xicoy B; Morgades M; Oriol A; Tormo M; del Potro E; Debén G; Abella E; Bethencourt C; Ortín X; Brunet S; Ortega-Rivas F; Novo A; López R; Hernández-Rivas JM; Sanz MA; Feliu E;
    Eur J Haematol; 2007 Feb; 78(2):102-10. PubMed ID: 17087744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized trial of induction therapy (daunorubicin, vincristine, prednisone versus daunorubicin, vincristine, prednisone, cytarabine and 6-thioguanine) in adult acute lymphoblastic leukemia with long-term follow-up: an Eastern Cooperative Oncology Group Study (E3486).
    Wiernik PH; Cassileth PA; Leong T; Hoagland HC; Bennett JM; Paietta E; Oken MM;
    Leuk Lymphoma; 2003 Sep; 44(9):1515-21. PubMed ID: 14565653
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment results of three consecutive Brazilian cooperative childhood ALL protocols: GBTLI-80, GBTLI-82 and -85. ALL Brazilian Group.
    Brandalise S; Odone V; Pereira W; Andrea M; Zanichelli M; Aranega V
    Leukemia; 1993 Aug; 7 Suppl 2():S142-5. PubMed ID: 8361220
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.